The current practice of psychiatric pharmacy is incredibly varied in terms of practice setting, activities performed, and services provided. This paper provides a description of the current clinical landscape of psychiatric pharmacy. This study is notable for being the first comprehensive survey of current psychiatric pharmacy practice in the United States.
According to the literature reviewed, there is evidence to suggest that having a psychiatric pharmacist on the health care team improves patient outcomes across a wide variety of inpatient and outpatient settings from general practice to specialized services.
Last Updated: 2022-02-07
One of AAPP’s primary strategies is to partner with others in the health professions through coalitions. This collective work allows us to advocate for legislation and regulation that is favorable toward the profession and the patients we serve but with a much bigger, more powerful voice. To see coalition letters that AAPP has joined, click here. Partnering with coalitions:
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients, improving outcomes and saving lives.
Self-reported opioid misuse within the past year occurred in almost 10 million participants over the age of 12 who participated in the 2020 National Survey on Drug Use and Health. In the same survey, 2.7 million self-reported a diagnosis of opioid use disorder, approximately 700,000 individuals reported a heroin related substance use disorder, and about 2.3 million participants reported a prescription pain reliever substance use disorder
